Większość akcjonariuszy spółki matki (mimo że u nich głosowali prawo do przeprowadzenia megaemisji, a u nas na razie akcji nie przybywa) widzi sprawy równie optymistycznie jak my, o czym mogą świadczyć np. takie komentarze na Stocktwits:
Mastery06:33 PM$MLSS "Brent Johnston, President of Milestone Scientific, commented, "Going forward, our commercial rollout strategy involves several key steps. Firstly, we are building upon the nine completed and published clinical studies and have begun meeting with Group Purchasing Organizations (GPO) in order to obtain approval of the CompuFlo® Epidural System within their facilities. Some of these GPOs have between 3,000 to 5,000 hospitals within their network. Getting this approval should shorten the sales cycle and open us up to large markets. " Do the math.